New York State Teachers Retirement System boosted its position in Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) by 0.4% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 55,152 shares of the medical equipment provider’s stock after buying an additional 200 shares during the period. New York State Teachers Retirement System’s holdings in Zeltiq Aesthetics were worth $3,067,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ameritas Investment Partners Inc. purchased a new position in Zeltiq Aesthetics during the first quarter worth approximately $170,000. First Citizens Bank & Trust Co. bought a new stake in Zeltiq Aesthetics during the first quarter valued at about $206,000. Peak Asset Management LLC bought a new stake in Zeltiq Aesthetics during the first quarter valued at about $219,000. State of Alaska Department of Revenue boosted its stake in Zeltiq Aesthetics by 2.8% in the first quarter. State of Alaska Department of Revenue now owns 4,010 shares of the medical equipment provider’s stock valued at $222,000 after buying an additional 110 shares in the last quarter. Finally, Princeton Alpha Management LP bought a new stake in Zeltiq Aesthetics during the first quarter valued at about $223,000.
Zeltiq Aesthetics Inc (NASDAQ ZLTQ) remained flat at $56.48 during mid-day trading on Tuesday. The firm has a 50 day moving average of $56.05 and a 200 day moving average of $46.95. Zeltiq Aesthetics Inc has a 12-month low of $23.58 and a 12-month high of $56.50.
Several analysts recently issued reports on the stock. Aegis reaffirmed a “hold” rating and issued a $56.00 price target on shares of Zeltiq Aesthetics in a report on Monday, April 24th. Zacks Investment Research raised shares of Zeltiq Aesthetics from a “hold” rating to a “buy” rating and set a $63.00 price target on the stock in a report on Thursday, April 13th. Nine equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $50.94.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians.
Receive News & Ratings for Zeltiq Aesthetics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc and related companies with our FREE daily email newsletter.